CAM
Close Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $34K | Hold |
268
| – | – | ﹤0.01% | 182 |
|
2025
Q1 | $30K | Hold |
268
| – | – | ﹤0.01% | 174 |
|
2024
Q4 | $37K | Hold |
268
| – | – | ﹤0.01% | 162 |
|
2024
Q3 | $31K | Hold |
268
| – | – | ﹤0.01% | 182 |
|
2024
Q2 | $37K | Hold |
268
| – | – | ﹤0.01% | 172 |
|
2024
Q1 | $37K | Hold |
268
| – | – | ﹤0.01% | 169 |
|
2023
Q4 | $35K | Hold |
268
| – | – | ﹤0.01% | 163 |
|
2023
Q3 | $30K | Hold |
268
| – | – | ﹤0.01% | 159 |
|
2023
Q2 | $25K | Hold |
268
| – | – | ﹤0.01% | 185 |
|
2023
Q1 | $27K | Hold |
268
| – | – | ﹤0.01% | 168 |
|
2022
Q4 | $32K | Hold |
268
| – | – | ﹤0.01% | 139 |
|
2022
Q3 | $28K | Hold |
268
| – | – | ﹤0.01% | 133 |
|
2022
Q2 | $26K | Hold |
268
| – | – | ﹤0.01% | 136 |
|
2022
Q1 | $23K | Hold |
268
| – | – | ﹤0.01% | 157 |
|
2021
Q4 | $23K | Hold |
268
| – | – | ﹤0.01% | 157 |
|
2021
Q3 | $26K | Hold |
268
| – | – | ﹤0.01% | 155 |
|
2021
Q2 | $26K | Hold |
268
| – | – | ﹤0.01% | 146 |
|
2021
Q1 | $26K | Hold |
268
| – | – | ﹤0.01% | 153 |
|
2020
Q4 | $26K | Hold |
268
| – | – | ﹤0.01% | 103 |
|
2020
Q3 | $26K | Hold |
268
| – | – | ﹤0.01% | 108 |
|
2020
Q2 | $33K | Hold |
268
| – | – | ﹤0.01% | 110 |
|
2020
Q1 | $23K | Hold |
268
| – | – | ﹤0.01% | 117 |
|
2019
Q4 | $29K | Hold |
268
| – | – | ﹤0.01% | 125 |
|
2019
Q3 | $24K | Hold |
268
| – | – | ﹤0.01% | 131 |
|
2019
Q2 | $23K | Hold |
268
| – | – | ﹤0.01% | 137 |
|
2019
Q1 | $24K | Sell |
268
-1,039,174
| -100% | -$93.1M | ﹤0.01% | 148 |
|
2018
Q4 | $106M | Buy |
1,039,442
+1,039,174
| +387,751% | +$106M | 11.7% | 2 |
|
2018
Q3 | $33K | Sell |
268
-100
| -27% | -$12.3K | ﹤0.01% | 141 |
|
2018
Q2 | $29K | Hold |
368
| – | – | ﹤0.01% | 140 |
|
2018
Q1 | $29K | Hold |
368
| – | – | ﹤0.01% | 146 |
|
2017
Q4 | $29K | Hold |
368
| – | – | ﹤0.01% | 141 |
|
2017
Q3 | $23K | Hold |
368
| – | – | ﹤0.01% | 142 |
|
2017
Q2 | $17K | Hold |
368
| – | – | ﹤0.01% | 159 |
|
2017
Q1 | $16K | Hold |
368
| – | – | ﹤0.01% | 157 |
|
2016
Q4 | $14K | Buy |
+368
| New | +$14K | ﹤0.01% | 122 |
|